Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients.

Jeffrey S HochHeather K BarrAndrea M GuggenbicklerCarolyn S Dewa

Published in: Current oncology (Toronto, Ont.) (2022)

The evidence suggests that there is good reason to believe that SCPs are an economically attractive way to improve outcomes for cancer patients when SCPs are offered in conjunction with standard cancer care.

Keyphrases

smoking cessation
replacement therapy
public health
glycemic control